← Back to Clinical Trials
Recruiting NCT05142150

Palliation in Gynae-oncology: Patients Expectations and Assessment of Care (PEACE)

Trial Parameters

Condition Gynaecological Cancer
Sponsor Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Study Type OBSERVATIONAL
Phase N/A
Enrollment 73
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2023-01-12
Completion 2025-12-31
Interventions
Questionaire

Brief Summary

The overall aim is to assess the feasibility and acceptability of collecting data on the patients and carers perception of care as well as to prospectively monitor end of life care.

Eligibility Criteria

Inclusion Criteria: A patient will be eligible for inclusion only if all of the following criteria are fulfilled: 1. Patients with any advanced gynecological malignancy and a life expectancy of approximately 4 months as estimated by their treating physician\*. Potential patient groups include, but are not limited to, those with platinum-resistant/refractory recurrent epithelial ovarian cancer (PRR-EOC), metastatic/recurrent cervical or endometrial cancer progressing after platinum-based chemotherapy; high grade/undifferentiated metastatic uterine sarcoma progressing after first-line chemotherapy etc. 2. Patients may be on active cancer treatment, about to commence active cancer treatment or under observation/palliative care. 3. Age ≥ 18 years 4. Able (both physically and cognitively) to complete patient-reported outcome measures independently in languages that are available in this study (i.e. without assistance from hospital translator). Exclusion Criteria: A patient will not be eligi

Related Trials